GLP-1 Trends
GLP-1 agonists have become increasingly popular as a treatment option for type 2 diabetes and obesity. These medications continue to […]
Blog, Maxor, MaxorPlus
MaxorPlus
Blog, Maxor, MaxorPlus
Biosimilar Trends
Biosimilars represent both a significant opportunity and challenge for the biopharmaceutical industry. Download our trend report to learn more about
Blog, Maxor, MaxorPlus
Cell and Gene Therapy
As the field of cell and gene therapy advances, new opportunities will emerge for healthcare stakeholders, including payers, providers, and
Blog, Clinical News, MaxorPlus
Laying the Foundation for an Innovative 2024 in Pharmacy Benefit Management
Reflecting on 2023 As we look back on 2023, the pharmacy benefit market experienced dramatic changes. With the launch of
Blog, MaxorPlus
Three Years and Counting…
We are excited to share that MaxorPlus has won the Top Workplace Award for the 3rd year in a row!
Blog, Clinical News, MaxorPlus
GLP-1: How to Decide What is Best for Your Plan
The GLP-1 class of medications for diabetes and weight loss is a hot topic right now. However, there is some
Blog, MaxorPlus
Humira Biosimilar Options
MaxorPlus is now offering Humira biosimilar options with select standard formularies. Humira is a prescription injection used to treat rheumatoid
Blog, MaxorPlus
Rewarding Members with Dynamic Discounts
Lowering Member Costs & Improving Member Adherence The MaxorPlus Dynamic Discounts Program, powered by Sempre Health, improves adherence by rewarding
Blog, Clinical News, MaxorPlus
Naloxone Nasal Spray OTC Approval and Opioid Management
Opioid Abuse: A Public Health Crisis The United States is experiencing a public health crisis of opioid use with drug
Utilization Management Approach to Reducing Drug Spend
Promoting the safe and appropriate use of medications is an integral step in managing drug spend and utilization across all